Press release
Telmisartan Market Growth Trend and Demand Outlook to 2027 - Macleods Pharmaceuticals, Zydus Pharmaceuticals, Torrent Pharmaceuticals, Jubilant Cadista, Aurobindo Pharma, Solco Healthcare
The Insight Partners
Telmisartan Market to 2027 - Global Analysis and Forecasts Indication (Hypertension, Cardiac Arrest, Stroke); Composition (Single, Combinational); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography
Telmisartan is an angiotensin receptor blocker (ARB) used alone or in combination with other agents for treatment of hypertension, stroke management and cardiac arrest. Telmisartan is available in different strengths tablets in generic forms and under trade name Micardis. Telmisartan also has its side effects that includes dizziness, lightheadedness, cough, sinus pain and others.
Get Sample Copy at https://www.theinsightpartners.com/sample/TIPRE00005565?sk
The report also includes the profiles of key Telmisartan market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Mylan N.V.
- Hikma Pharmaceuticals PLC
- Exelan Pharmaceuticals, Inc.
- Macleods Pharmaceuticals Ltd.
- Zydus Pharmaceuticals, Inc.
- Torrent Pharmaceuticals Ltd.
- Jubilant Cadista.
- Aurobindo Pharma.
- Solco Healthcare
- Sandoz International GmbH
The reports cover key developments in the Telmisartan market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Telmisartan market are anticipated to lucrative growth opportunities in the future with the rising demand for Telmisartan in the global market. Below mentioned is the list of few companies engaged in the Telmisartan market.
Browse Complete Report at https://www.theinsightpartners.com/reports/telmisartan-market?sk
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Telmisartan Market - By Indication
1.3.2 Telmisartan Market - By Composition
1.3.3 Telmisartan Market - By Distribution Channel
1.3.4 Telmisartan Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TELMISARTAN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.3. EXPERT OPINIONS
5. TELMISARTAN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
Inquire more at https://www.theinsightpartners.com/inquiry/TIPRE00005565?sk
Contact us –
Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com
Website: https://www.theinsightpartners.com
About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Telmisartan Market Growth Trend and Demand Outlook to 2027 - Macleods Pharmaceuticals, Zydus Pharmaceuticals, Torrent Pharmaceuticals, Jubilant Cadista, Aurobindo Pharma, Solco Healthcare here
News-ID: 1780132 • Views: …
More Releases from The Insight Partners
Agricultural Lighting Market Estimated to Experience a Hike in Growth by 2031
The increasing adoption of indoor farming practices is a significant driver of the agricultural lighting market. As urbanization rises and arable land decreases, farmers are turning to controlled environment agriculture (CEA) to maximize yield. Advanced lighting solutions, such as LED grow lights, provide the necessary light spectrum for optimal plant growth, enabling year-round production. This shift towards indoor and vertical farming systems drives the demand for effective and energy-efficient agricultural…
Medical Device Validation and Verification Market Worth by 2031
Offers a comprehensive overview of the market's current state and future growth trajectory. It identifies key drivers, challenges, and opportunities, providing valuable insights for various business stakeholders. According to the report's forecast, the sector is set to witness a steady expansion in market size, market share, and innovation over the next six years.
Download Sample PDF @ https://www.theinsightpartners.com/sample/TIPRE00016735/?utm_source=OpenPR&utm_medium=10759
Key Growth Drivers
The press release details five major factors propelling the market forward:
1. Stringent…
Medical Vacuum Filters Market Positioned for Substantial Growth Through 2031
New York, US - August 28, 2025- A new market report from The Insight Partners projects a strong and steady expansion for the global medical vacuum filters market, fueled by a confluence of rising healthcare demands and technological innovation. The report, titled "Medical Vacuum Filters Market Share, Size, Trends, and Forecast by 2031," highlights that the sector is set for significant growth in both market size and innovation over the…
Growing Industrial Automation and IoT Driving the Level Translators Market
New York, US - August 21, 2025- The market for level translators is projected to grow significantly by 2031, fueled by the rise in industrial automation and the expanding use of consumer electronics, automotive systems, and IoT devices. According to a new report from The Insight Partners, this growth is driven by the increasing need for components that can seamlessly bridge the gap between devices operating at different voltage…
More Releases for Telmisartan
Hypertension: The Driving Force Behind Telmisartan Market Growth
Hypertension, or high blood pressure, remains a global health crisis, affecting millions worldwide. This prevalence creates a significant and sustained demand for effective antihypertensive medications, positioning the Telmisartan market as a high-opportunity segment within the broader pharmaceutical landscape.
Market Dynamics and Growth Drivers
Telmisartan, an angiotensin II receptor blocker (ARB), is a widely prescribed medication for the treatment of hypertension. Its efficacy in lowering blood pressure, coupled with a generally well-tolerated safety…
Telmisartan Dispersible Tablets Market: A Comprehensive Overview
As of 2023, the global telmisartan dispersible tablets market is valued at approximately USD 1.2 billion and is projected to reach around USD 2.1 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.5% from 2024 to 2032.
Telmisartan Dispersible Tablets Market Overview
The telmisartan dispersible tablets market is experiencing steady growth, primarily driven by the increasing prevalence of hypertension and cardiovascular diseases worldwide. Telmisartan, an angiotensin receptor…
Telmisartan Market Size, Share, Trends Report and Forecast 2024-2032
The telmisartan market value was USD 4 billion in 2023, driven by the global prevalence of hypertension, and aging populations. The market size is anticipated to grow at a CAGR of 3.5% during the forecast period of 2024-2032 to achieve a value of USD 5.4 billion by 2032.
Telmisartan: Introduction
Telmisartan is a widely used medication belonging to the class of angiotensin II receptor blockers (ARBs). It is primarily prescribed for the…
Telmisartan Market Report 2024-2032: Key Findings and Outlook
The global Telmisartan market is on an upward trajectory, reflecting a value of USD 3.38 billion in 2023. This remarkable growth can be attributed to the increasing prevalence of cardiovascular diseases, particularly hypertension, which has been exacerbated by pandemic-induced stress, sedentary lifestyles, and a growing geriatric population. As we delve into the future, it's projected that the market will continue to expand, poised to achieve a substantial value of USD…
Global Telmisartan Market Size, Segmentations, Top Key Players, Trends, & Foreca …
Telmisartan is a medication used to treat high blood pressure, heart failure, and other cardiovascular conditions. It belongs to a class of drugs called angiotensin II receptor blockers (ARBs), which work by relaxing blood vessels and improving blood flow.
The global market for telmisartan is driven by a growing incidence of hypertension and other cardiovascular diseases, as well as increasing demand for effective and affordable treatments. According to a report by…
Research on Global Telmisartan Market to Offer Outlook on Growth Opportunities
The most recent study on the telmisartan market by Dhirtek Business Research and Consulting provides a comprehensive view of the entire market. The research report delves deeply into the drivers and restraints of the global telmisartan market. Analysts have conducted extensive research on the global telmisartan market's milestones and current trends that will determine its future. An in-depth report on the topic was created using primary and secondary research methods.…
